Abl tyrosine kinase in signal transduction and cell-cycle regulation - PubMed (original) (raw)
Review
Abl tyrosine kinase in signal transduction and cell-cycle regulation
J Y Wang. Curr Opin Genet Dev. 1993 Feb.
Abstract
Although the biological function of the c-Abl tyrosine kinase remains unsolved, potentially productive avenues towards the elucidation of that function have been identified by recent progress. An F-actin binding and a sequence-specific DNA-binding domain have been discovered in c-Abl, and DNA binding has been shown to be cell-cycle regulated. Deletion of those two domains in the mouse c-Abl results in a loss of biological function despite the production of an active tyrosine kinase. These findings suggest a role for c-Abl in the regulation of processes occurring on F-actin and on specific DNA elements.
Similar articles
- Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL, Hoffmann FM. Juang JL, et al. Oncogene. 1999 Sep 16;18(37):5138-47. doi: 10.1038/sj.onc.1202911. Oncogene. 1999. PMID: 10498863 - Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
Allen PB, Morgan GJ, Wiedemann LM. Allen PB, et al. Baillieres Clin Haematol. 1992 Oct;5(4):897-930. doi: 10.1016/s0950-3536(11)80051-x. Baillieres Clin Haematol. 1992. PMID: 1308169 Review. - c-Abl in oxidative stress, aging and cancer.
Li B. Li B. Cell Cycle. 2005 Feb;4(2):246-8. Epub 2005 Feb 21. Cell Cycle. 2005. PMID: 15655364 - Signal transduction by wild-type and leukemogenic Abl proteins.
Raitano AB, Whang YE, Sawyers CL. Raitano AB, et al. Biochim Biophys Acta. 1997 Dec 9;1333(3):F201-16. doi: 10.1016/s0304-419x(97)00023-1. Biochim Biophys Acta. 1997. PMID: 9426204 Review. No abstract available. - The capable ABL: what is its biological function?
Wang JY. Wang JY. Mol Cell Biol. 2014 Apr;34(7):1188-97. doi: 10.1128/MCB.01454-13. Epub 2014 Jan 13. Mol Cell Biol. 2014. PMID: 24421390 Free PMC article. Review.
Cited by
- Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes.
Stevenson M, Algarzae NK, Moussa C. Stevenson M, et al. Front Dement. 2024 Aug 16;3:1458038. doi: 10.3389/frdem.2024.1458038. eCollection 2024. Front Dement. 2024. PMID: 39221072 Free PMC article. Review. - ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.
Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X, Yue J, Hu Y, Liu H, Zhu L, Niu X, Zheng T, Zhang X, Jin J, Wang T, Ju R, Wang C, Jiang Q, Gao T, Jin Y, Li P, Wang Y, Zhang C, Wang GF, Cao C, Liu X. Dong Q, et al. Cell Death Differ. 2024 Oct;31(10):1285-1301. doi: 10.1038/s41418-024-01339-w. Epub 2024 Jul 26. Cell Death Differ. 2024. PMID: 39060421 Free PMC article. - Human NTHL1 expression and subcellular distribution determines cisplatin sensitivity in human lung epithelial and non-small cell lung cancer cells.
Kar A, Degtyareva NP, Doetsch PW. Kar A, et al. NAR Cancer. 2024 Feb 21;6(1):zcae006. doi: 10.1093/narcan/zcae006. eCollection 2024 Mar. NAR Cancer. 2024. PMID: 38384388 Free PMC article. - Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report.
Liu H, Bai H, Zhang S, Zhao X, Mao D, Xi R. Liu H, et al. Int J Hematol. 2023 Jun;117(6):929-932. doi: 10.1007/s12185-023-03531-z. Epub 2023 Jan 24. Int J Hematol. 2023. PMID: 36694063 - Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation.
Daniels HG, Knicely BG, Miller AK, Thompson A, Plattner R, Goellner EM. Daniels HG, et al. Front Genet. 2022 Oct 20;13:940073. doi: 10.3389/fgene.2022.940073. eCollection 2022. Front Genet. 2022. PMID: 36338985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous